Death Rattle Management — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Hyoscine hydrobromide SC 400 μg q4h
Audible respiratory secretions in the dying patient (death rattle) are managed with anticholinergic agents (hyoscine hydrobromide or glycopyrronium) to reduce new secretion production. Suctioning is generally avoided (distressing, ineffective at deep secretions, and may stimulate more secretion). Repositioning (semi-prone) may help. Family reassurance is important — the patient is typically unconscious and not distressed.
Reference: PCA – 2024 – Terminal Phase Care; eTG Palliative Care 2024